GenesisCare Leeds recruits founding breast cancer CNS to build specialist service from the ground up

GenesisCare is opening a new cancer care centre in Leeds, and the first Clinical Nurse Specialist for breast cancer will sit at the centre of that launch. The post is not a routine staffing addition. It is a service-building role, designed to shape care pathways, coordinate multidisciplinary work and act as the patient’s key clinical contact from the outset.

The position places specialist nursing at the front of a new oncology service rather than at its periphery. In breast cancer care, that matters because diagnosis, staging, systemic treatment, surgery, radiotherapy and follow-up often unfold across multiple teams and settings. A nurse specialist who understands the full pathway can reduce fragmentation, keep patients oriented during fast-moving decisions and help translate treatment plans into practical daily care.

The Leeds role is permanent and full time, with a salary range of £48,000 to £56,000 a year. It is aimed at a registered adult nurse with current NMC registration and significant post-registration experience in breast cancer care, oncology or a closely related specialty. Previous work as a Clinical Nurse Specialist or in an advanced practice role would strengthen an application, but the core requirement is clear: deep familiarity with complex cancer pathways and the ability to work independently while remaining tightly linked to consultants and the wider team.

Care coordination will define the post from day one

The job description frames the CNS as the designated Key Worker for patients undergoing treatment. In practical terms, that means a single clinical point of contact for patients and families navigating a diagnosis that often arrives with fear, uncertainty and a long list of unfamiliar decisions. The nurse will manage a specialist caseload, perform holistic needs assessments and develop personalised care plans tailored to each patient’s situation.

Those responsibilities extend beyond emotional support, although that component is central. A breast cancer CNS often becomes the clinician who notices when symptoms are escalating, when treatment-related toxicity is changing a patient’s ability to function, or when social and psychological barriers are interfering with adherence. Coordinating care across consultants, nursing teams and external healthcare providers can prevent delays and reduce the risk that important issues fall between appointments.

A single nurse can change the tempo of a cancer pathway.

The post also includes nurse-led clinics and participation in multidisciplinary team meetings. Those elements suggest a role embedded in daily clinical operations rather than a purely advisory function. Nurse-led review can support symptom management, reinforce treatment education and give patients a structured place to raise concerns without waiting for the next physician appointment. In breast oncology, where pathways can include surgery, neoadjuvant therapy, adjuvant therapy and survivorship planning, that continuity can be clinically valuable.

Patient education and self-management sit alongside specialist treatment

The Leeds centre is being positioned as part of GenesisCare’s broader UK oncology network, and the organisation describes its model as integrated, personalized cancer care. The role reflects that philosophy by asking the CNS to provide specialist advice, education and emotional support across the patient journey. Promoting self-management is part of the brief, which means helping patients understand symptoms, treatment effects and when to seek urgent review.

That educational function has a direct bedside purpose. Breast cancer treatment can affect fatigue, mood, sleep, pain, wound healing, lymphatic function and daily activity, and the way those problems are explained often determines whether patients feel able to continue treatment safely. A skilled CNS can make complex plans usable, and that can influence both patient confidence and continuity of care.

The post also asks the nurse to contribute to service development, quality improvement and clinical governance. In a new centre, those duties are especially important. Protocols, referral pathways, documentation standards and escalation processes have to be built early and tested in real clinical use. A founding CNS can help define how the service runs, where the pressure points are likely to emerge and how the centre can maintain evidence-based care as activity grows.

A new Leeds centre brings specialist oncology capacity into focus

GenesisCare presents itself as a leading private oncology provider in the UK, with services that include advanced diagnostics, medical oncology, radiotherapy and theranostics. The Leeds centre is being added to that network, and the breast CNS role appears intended to anchor the patient experience from first presentation through ongoing treatment support. The service description emphasizes whole-patient care, including wellbeing services and exercise medicine, alongside cancer-directed therapy.

That model reflects a broader reality in oncology: outcomes are shaped not only by drugs, scans and procedures, but also by whether patients can move through treatment safely, understand what is happening and access timely advice when symptoms change. Specialist nursing often provides the structure that holds those elements together. Without it, a new centre can still deliver treatment, but the pathway may feel disjointed to patients and families.

For nurses considering the role, the appeal lies in the combination of autonomous practice and service creation. The post asks for independent judgement, but it also requires close collaboration with consultants and multidisciplinary colleagues. The successful applicant will not simply inherit an established workflow; they will help write it.

The package includes 25 days of annual leave plus bank holidays, the option to buy or sell leave, private medical insurance, dental cover, an employee assistance programme, contributory pension access, wellbeing support and free parking at most centres. Those benefits help explain the employer’s recruitment pitch, but the larger clinical story is the opening of a new breast cancer service in Leeds and the decision to place specialist nursing at its core.

For breast cancer patients, the value of that choice will be measured in smoother coordination, clearer communication and faster answers during a difficult treatment journey. The first CNS will be responsible for turning the new centre’s clinical ambitions into a usable pathway, one patient at a time.


Reporting by Dr. Marcus Reed, MD, PhD for Medicine World Foundation, with additional data provided by MHRA (UK) Official Updates.